Abstract:Background: Interferons are natural messenger proteins that are used to treat various disease entities. Due to their immunomodulating, antiviral and antiproliferative effects, the systemic administration of interferons after ablative treatment for anogenital warts (AGWs) has been advocated to increase clearance and decrease recurrence rates. However, studies investigating the efficacy of adjuvant systemic interferon have yielded inconsistent results. The objective of this systematic review and meta-analysis was to comprehensively assess and evaluate the available evidence from randomised controlled trials. Methods: A literature search was conducted in Cochrane Central Register of Controlled Trials, Embase and MEDLINE. Available data were classified according to the interferon type and dosage. Pooled effect estimates were calculated for predefined outcomes. The Cochrane Collaboration's risk of bias tool was used to assess the included trials and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to evaluate our confidence in the effect estimates. Results: Twelve trials were identified that met the inclusion criteria and assessed immunocompetent patients with external AGW. Compared with placebo, adjuvant alpha-, beta- and gamma-interferon were generally not significantly superior in terms of complete clearance over the short, intermediate or long term, nor with regard to intermediate- or long-term recurrence. However, the low-dose subgroup of adjuvant alpha-interferon was significantly superior compared with placebo regarding intermediate-term complete clearance and recurrence. Further data were available for the comparison of different dosages of alpha- and beta-interferon and for comparisons of the three interferon types. No significant differences were seen in these comparisons regarding efficacy. Data on quality of life were not available. Conclusions: The GRADE quality of the evidence ranged from 'very low' to 'high'. The significantly higher efficacy of low-dose alpha-interferon compared with placebo was based on a single trial, and our confidence in the effect estimates rated as 'low'. Overall, we found no reliable evidence favouring the systemic use of interferon after ablative treatment of AGW.

[Postoperative interferon hydrogel treatment. A method for the successful therapy of chronic persistent giant condylomas in an immunologically deficient patient with Hodgkin's disease]

Double -Blind Randomized Multicenter Controlled Clinical Trial of Recombinant Interferon Α- 2a Gel Versus Placebo in Prevention of Condyloma Acuminata Relapse

Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon

Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

The Anti‐condyloma Acuminatum Effects of Interferon‐inducible Protein 10 in Vitro

Successful combination therapy of trichloroacetic acid, podophyllin, and electrocautery on giant condylomata acuminata

Photodynamic therapy combined with surgical management of extensive anogenital condylomatosis in a patient with systemic lupus erythematosus

Efficacy of Fulguration Combined with Imiquimod Cream on Condyloma Acuminatum, and the Effect on Immune Functions and Serums Levels of IL-2 and IL-10

Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials

Interferon alpha-2b treatment for exophytic nasal papillomas and human papillomavirus infection

Efficacy of electrocauterization combined 5-aminolevulinic acid photodynamic therapy and interferon injection in the treatment of cervical condyloma acuminatum

Clinical Study on Combining Interferon and HIFU to Treat Severe Cervical Erosion

Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization

Efficacy and Safety of Giant Condyloma Acuminatum with Monotherapy of Topical Traditional Chinese Medicine: Report of Eight Cases

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial.

(185) Safety And Preliminary Efficacy Of Phase 1 Trial Targeting Hpv16 Infection And Cervical Lesions With Interferon-Inducing Viral Vector Delns/E6E7: A Placebo-Controlled Study With 28 Patients

The Curative Effect of Recombinant Human Interferon Α-2B Gel on Flooding Prevention in Loop Electrosurgical Excision Procedure

Low molecular weight bioregulator of bacterial origin in condylomatosis therapy optimization

The Topical Novel Formulations of Interferon α-2в Effectively Inhibit HSV-1 Keratitis in the Rabbit Eye Model and HSV-2 Genital Herpes in Mice

A Double-blind Randomized Controlled Clinical Trial of Recombinant Interferon α-2a Gel Versus Placebo in Treatment of Herpes Simplex